Sign in

CIK 0001755237

  • Non-accelerated filer
  • Smaller reporting company

Korsana Biosciences, Inc.

Sign in to watch
Ticker
KRSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
831895370
Phone
+1 781-516-2325
Business address
203 CRESCENT STREET, BLDGS. #3/3A/4, SUITE 503, WALTHAM, MA, 02453
Former names
Cyclerion Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 626,117 shares at $16.00 ($10,017,872)
  7. 4 Open-market buy Director bought 626,117 shares at $16.00 ($10,017,872)
  8. 4/A Grant or award Director acquired 2,421 shares (grant or award)
  9. 4 Grant or award Director acquired 18,120 shares (grant or award)
  10. 4/A Grant or award Director acquired 16,950 shares (grant or award)
  11. 4 Grant or award Chief Executive Officer acquired 224,647 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy President bought 270,107 shares at $14.81 ($4,000,285)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Chief Financial Officer acquired 77,506 shares (grant or award)
  17. 4 Grant or award Director acquired 7,508 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award Director acquired 16,950 shares (grant or award)
  20. 4 Grant or award Director acquired 2,421 shares (grant or award)

Page 6 of 7 · 134 filings